TICKERNOMICS Sign up
Last Update: 2024-12-27 15:30:09
Bluejay Diagnostics Inc. ( BJDX ) https://www.bluejaydx.com
3.75USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-99.21%
BJDX
SPY
32.66%
-99.98%
BJDX
SPY
108.59%
BJDX
0.00%
SPY
302.52%
BJDX
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
36.31
30.80
0.04
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-4.23
21.38
5.07
-256.56
0.00
-4.51
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-167.54
-3.75
-117.84
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
-90.05
-94.09
0.00
Other Earnings and Cash Flow Stats:
Bluejay Diagnostics Inc. ( BJDX ) Net Income TTM ($MM) is -8.59
Bluejay Diagnostics Inc. ( BJDX ) Operating Income TTM ($MM) is -8.07
Bluejay Diagnostics Inc. ( BJDX ) Owners' Earnings Annual ($MM) is 0.00
Bluejay Diagnostics Inc. ( BJDX ) Current Price to Owners' Earnings ratio is 0.00
Bluejay Diagnostics Inc. ( BJDX ) EBITDA TTM ($MM) is -7.85
Bluejay Diagnostics Inc. ( BJDX ) EBITDA Margin is -117.84%
Capital Allocation:
Bluejay Diagnostics Inc. ( BJDX ) has paid 0.00 dividends per share and bought back -9.417984 million shares in the past 12 months
Bluejay Diagnostics Inc. ( BJDX ) has reduced its debt by 0.147157 million USD in the last 12 months
Capital Structure:
Bluejay Diagnostics Inc. ( BJDX ) Interest-bearing Debt ($MM) as of last quarter is 0
Bluejay Diagnostics Inc. ( BJDX ) Annual Working Capital Investments ($MM) are 2
Bluejay Diagnostics Inc. ( BJDX ) Book Value ($MM) as of last quarter is 7
Bluejay Diagnostics Inc. ( BJDX ) Debt/Capital as of last quarter is 3%
Other Balance Sheet Stats:
Bluejay Diagnostics Inc. ( BJDX ) has 5 million in cash on hand as of last quarter
Bluejay Diagnostics Inc. ( BJDX ) has 1 million of liabilities due within 12 months, and long term debt 0 as of last quarter
Bluejay Diagnostics Inc. ( BJDX ) has 9 common shares outstanding as of last quarter
Bluejay Diagnostics Inc. ( BJDX ) has 0 million USD of preferred stock value
Academic Scores:
Bluejay Diagnostics Inc. ( BJDX ) Altman Z-Score is 11.46 as of last quarter
Bluejay Diagnostics Inc. ( BJDX ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
Bluejay Diagnostics Inc. ( BJDX ) largest shareholder is TWO SIGMA SECURITIES, LLC owning 0 shares at 0.00 ($MM) value
Kenneth R Fisher(an insider) Bought 1000 shares of Bluejay Diagnostics Inc. ( BJDX ) for the amount of $19800.00 on 2022-04-25
1.15% of Bluejay Diagnostics Inc. ( BJDX ) is held by insiders, and 0.95% is held by institutions
Bluejay Diagnostics Inc. ( BJDX ) went public on 2021-11-10
Other Bluejay Diagnostics Inc. ( BJDX ) financial metrics:
FCF:-8.99
Unlevered Free Cash Flow:0.00
EPS:-0.01
Operating Margin:-167.54
Gross Profit Margin:-3.75
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-82.74
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Bluejay Diagnostics Inc. ( BJDX ) :
Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.